Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083171498> ?p ?o ?g. }
- W2083171498 abstract "IL-17A is a pro-inflammatory cytokine that is normally associated with autoimmune arthritis and other pro-inflammatory conditions. Recently, IL-17A has emerged as a critical factor in enhancing breast cancer (BC)-associated metastases. We generated immune competent arthritic mouse models that develop spontaneous BC-associated bone and lung metastasis. Using these models, we have previously shown that neutralization of IL-17A resulted in significant reduction in metastasis. However, the underlying mechanism/s remains unknown.We have utilized two previously published mouse models for this study: 1) the pro-arthritic mouse model (designated SKG) injected with metastatic BC cell line (4T1) in the mammary fat pad, and 2) the PyV MT mice that develop spontaneous mammary gland tumors injected with type II collagen to induce autoimmune arthritis. Mice were treated with anti-IL-17A neutralizing antibody and monitored for metastasis and assessed for pro-inflammatory cytokines and chemokines associated with BC-associated metastasis.We first corroborate our previous finding that in vivo neutralization of IL-17A significantly reduced metastasis to the bones and lungs in both models. Next, we report that treatment with anti-IL17A antibody significantly reduced the expression of a key chemokine, CXCL12 (also known as stromal derived factor-1 (SDF - 1)) in the bones and lungs of treated mice. CXCL12 is a ligand for CXCR4 (expressed on BC cells) and their interaction is known to be critical for metastasis. Interestingly, levels of CXCR4 in the tumor remained unchanged with treatment. Consequently, protein lysates derived from the bones and lungs of treated mice were significantly less chemotactic for the BC cells than lysates from untreated mice; and addition of exogenous SDF-1 to the lysates from treated mice completely restored BC cell migration. In addition, cytokines such as IL-6 and M-CSF were significantly reduced in the lung and bone lysates following treatment. The data presented suggests that systemic neutralization of IL-17A can block the CXCR4/SDF-1 signaling pathway by reducing the expression of SDF-1 in the metastatic niches and significantly reducing metastasis in both mouse models.In our model, neutralization of IL-17A regulates SDF-1 expression in the metastatic niches either directly or indirectly via reducing levels of IL-6 and M-CSF." @default.
- W2083171498 created "2016-06-24" @default.
- W2083171498 creator A5007863237 @default.
- W2083171498 creator A5014244148 @default.
- W2083171498 creator A5036197432 @default.
- W2083171498 creator A5045937236 @default.
- W2083171498 creator A5065658887 @default.
- W2083171498 creator A5083698757 @default.
- W2083171498 date "2014-03-27" @default.
- W2083171498 modified "2023-10-18" @default.
- W2083171498 title "Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches" @default.
- W2083171498 cites W150729901 @default.
- W2083171498 cites W1513992440 @default.
- W2083171498 cites W1553271826 @default.
- W2083171498 cites W1566169834 @default.
- W2083171498 cites W1669486342 @default.
- W2083171498 cites W1965037168 @default.
- W2083171498 cites W1965570423 @default.
- W2083171498 cites W1968031873 @default.
- W2083171498 cites W1973534046 @default.
- W2083171498 cites W1975109100 @default.
- W2083171498 cites W1975826537 @default.
- W2083171498 cites W1983591605 @default.
- W2083171498 cites W1984182254 @default.
- W2083171498 cites W2000000541 @default.
- W2083171498 cites W2008179404 @default.
- W2083171498 cites W2025441457 @default.
- W2083171498 cites W2046957298 @default.
- W2083171498 cites W2051942032 @default.
- W2083171498 cites W2056884098 @default.
- W2083171498 cites W2076748180 @default.
- W2083171498 cites W2079715544 @default.
- W2083171498 cites W2082833890 @default.
- W2083171498 cites W2088682910 @default.
- W2083171498 cites W2090715425 @default.
- W2083171498 cites W2095887087 @default.
- W2083171498 cites W2098280147 @default.
- W2083171498 cites W2105007932 @default.
- W2083171498 cites W2107088471 @default.
- W2083171498 cites W2107951685 @default.
- W2083171498 cites W2110555227 @default.
- W2083171498 cites W2110800021 @default.
- W2083171498 cites W2110845079 @default.
- W2083171498 cites W2111449140 @default.
- W2083171498 cites W2113472355 @default.
- W2083171498 cites W2114817620 @default.
- W2083171498 cites W2124221114 @default.
- W2083171498 cites W2127130742 @default.
- W2083171498 cites W2146607274 @default.
- W2083171498 cites W2149888039 @default.
- W2083171498 cites W2156323704 @default.
- W2083171498 cites W2158854771 @default.
- W2083171498 cites W2159490365 @default.
- W2083171498 cites W2160875647 @default.
- W2083171498 cites W2165948908 @default.
- W2083171498 cites W2168527367 @default.
- W2083171498 cites W2182021524 @default.
- W2083171498 doi "https://doi.org/10.1186/1471-2407-14-225" @default.
- W2083171498 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3986611" @default.
- W2083171498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24674692" @default.
- W2083171498 hasPublicationYear "2014" @default.
- W2083171498 type Work @default.
- W2083171498 sameAs 2083171498 @default.
- W2083171498 citedByCount "41" @default.
- W2083171498 countsByYear W20831714982014 @default.
- W2083171498 countsByYear W20831714982015 @default.
- W2083171498 countsByYear W20831714982016 @default.
- W2083171498 countsByYear W20831714982017 @default.
- W2083171498 countsByYear W20831714982018 @default.
- W2083171498 countsByYear W20831714982019 @default.
- W2083171498 countsByYear W20831714982020 @default.
- W2083171498 countsByYear W20831714982021 @default.
- W2083171498 countsByYear W20831714982022 @default.
- W2083171498 countsByYear W20831714982023 @default.
- W2083171498 crossrefType "journal-article" @default.
- W2083171498 hasAuthorship W2083171498A5007863237 @default.
- W2083171498 hasAuthorship W2083171498A5014244148 @default.
- W2083171498 hasAuthorship W2083171498A5036197432 @default.
- W2083171498 hasAuthorship W2083171498A5045937236 @default.
- W2083171498 hasAuthorship W2083171498A5065658887 @default.
- W2083171498 hasAuthorship W2083171498A5083698757 @default.
- W2083171498 hasBestOaLocation W20831714981 @default.
- W2083171498 hasConcept C121608353 @default.
- W2083171498 hasConcept C126322002 @default.
- W2083171498 hasConcept C13373296 @default.
- W2083171498 hasConcept C16930146 @default.
- W2083171498 hasConcept C203014093 @default.
- W2083171498 hasConcept C2775930923 @default.
- W2083171498 hasConcept C2777077863 @default.
- W2083171498 hasConcept C2777783956 @default.
- W2083171498 hasConcept C2778690821 @default.
- W2083171498 hasConcept C2779013556 @default.
- W2083171498 hasConcept C2780140570 @default.
- W2083171498 hasConcept C47348012 @default.
- W2083171498 hasConcept C502942594 @default.
- W2083171498 hasConcept C530470458 @default.
- W2083171498 hasConcept C71924100 @default.
- W2083171498 hasConcept C8891405 @default.
- W2083171498 hasConceptScore W2083171498C121608353 @default.
- W2083171498 hasConceptScore W2083171498C126322002 @default.